# Embera NeuroTherapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/embera-neurotherapeutics

- Industry: Pharmaceuticals
- Headquarters: Sudbury, US
- Website: www.emberaneuro.com
- Total disclosed funding: $7.9M
- Latest round: Series A (Dec 19, 2014)
- Investors on record: 4

## About

Founded in 2005 and based in Massachusetts, US, Embera NeuroTherapeutics, Inc. operates as a clinical-stage pharmaceutical company that engages in developing treatments for smoking cessation and other addictions.

## Funding rounds

- Series A, Dec 19, 2014, $2.4M — BVM Capital, Keiretsu Forum, HRA Pharma Rare Disease
- Series A, Aug 10, 2011, $4.5M — BVM Capital, Themelios Ventures
- Series A, Sep 3, 2008, $0.3M — BVM Capital
- Series A, Jan 23, 2007, $0.8M — BVM Capital

## Investors

- BVM Capital (https://capitalatlas.ai/funds/bvm-capital) — Series A
- Themelios Ventures — Series A
- Keiretsu Forum — Series A
- HRA Pharma Rare Disease — Series A